Annual CFI
-$6.65 M
-$2.80 M-72.51%
31 December 2023
Summary:
Core Laboratories NV annual cash flow from investing activities is currently -$6.65 million, with the most recent change of -$2.80 million (-72.51%) on 31 December 2023. During the last 3 years, it has fallen by -$14.50 million (-184.73%). CLB annual CFI is now -174.55% below its all-time high of $8.92 million, reached on 31 December 1999.CLB Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$491.00 K
+$196.00 K+28.53%
30 September 2024
Summary:
Core Laboratories NV quarterly cash flow from investing activities is currently -$491.00 thousand, with the most recent change of +$196.00 thousand (+28.53%) on 30 September 2024. Over the past year, it has increased by +$2.90 million (+85.51%). CLB quarterly CFI is now -102.36% below its all-time high of $20.82 million, reached on 31 December 1999.CLB Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$5.28 M
+$2.90 M+35.42%
30 September 2024
Summary:
Core Laboratories NV TTM cash flow from investing activities is currently -$5.28 million, with the most recent change of +$2.90 million (+35.42%) on 30 September 2024. Over the past year, it has dropped by -$2.13 million (-67.76%). CLB TTM CFI is now -145.41% below its all-time high of $11.63 million, reached on 30 June 2021.CLB TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLB Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -72.5% | +85.5% | -67.8% |
| 3 y3 years | -184.7% | +84.4% | -148.7% |
| 5 y5 years | +90.6% | +93.5% | +16.4% |
CLB Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -184.7% | +34.9% | -140.3% | +86.7% | -148.7% | +48.3% |
| 5 y | 5 years | -184.7% | +90.6% | -102.8% | +93.5% | -145.4% | +73.4% |
| alltime | all time | -174.6% | +92.9% | -102.4% | +99.3% | -145.4% | +94.3% |
Core Laboratories NV Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$491.00 K(-28.5%) | -$5.28 M(-35.4%) |
| June 2024 | - | -$687.00 K(-58.5%) | -$8.18 M(+30.4%) |
| Mar 2024 | - | -$1.66 M(-32.3%) | -$6.27 M(-5.7%) |
| Dec 2023 | -$6.65 M(+72.5%) | -$2.45 M(-27.8%) | -$6.65 M(+111.3%) |
| Sept 2023 | - | -$3.39 M(-377.7%) | -$3.15 M(+35.9%) |
| June 2023 | - | $1.22 M(-159.9%) | -$2.32 M(-63.4%) |
| Mar 2023 | - | -$2.04 M(-292.6%) | -$6.32 M(+64.0%) |
| Dec 2022 | -$3.86 M(-62.3%) | $1.06 M(-141.4%) | -$3.86 M(-55.2%) |
| Sept 2022 | - | -$2.56 M(-8.2%) | -$8.61 M(-6.5%) |
| June 2022 | - | -$2.79 M(-750.7%) | -$9.20 M(+5.5%) |
| Mar 2022 | - | $428.00 K(-111.6%) | -$8.72 M(-14.7%) |
| Dec 2021 | -$10.22 M(-230.2%) | -$3.69 M(+17.2%) | -$10.22 M(-194.2%) |
| Sept 2021 | - | -$3.15 M(+36.5%) | $10.85 M(-6.7%) |
| June 2021 | - | -$2.31 M(+115.7%) | $11.63 M(+9.0%) |
| Mar 2021 | - | -$1.07 M(-106.2%) | $10.66 M(+35.8%) |
| Dec 2020 | $7.85 M(-238.3%) | $17.38 M(-832.1%) | $7.85 M(-153.5%) |
| Sept 2020 | - | -$2.37 M(-27.4%) | -$14.66 M(-26.3%) |
| June 2020 | - | -$3.27 M(-15.8%) | -$19.89 M(+356.5%) |
| Mar 2020 | - | -$3.88 M(-24.3%) | -$4.36 M(-23.3%) |
| Dec 2019 | -$5.68 M(-92.0%) | -$5.13 M(-32.4%) | -$5.68 M(-10.1%) |
| Sept 2019 | - | -$7.60 M(-162.0%) | -$6.32 M(-87.4%) |
| June 2019 | - | $12.26 M(-335.5%) | -$50.27 M(-29.4%) |
| Mar 2019 | - | -$5.21 M(-9.9%) | -$71.23 M(+0.8%) |
| Dec 2018 | -$70.64 M(+243.6%) | -$5.77 M(-88.8%) | -$70.64 M(+0.7%) |
| Sept 2018 | - | -$51.55 M(+492.7%) | -$70.17 M(+192.9%) |
| June 2018 | - | -$8.70 M(+88.4%) | -$23.95 M(+29.1%) |
| Mar 2018 | - | -$4.62 M(-12.9%) | -$18.55 M(-9.8%) |
| Dec 2017 | -$20.56 M(+39.6%) | -$5.30 M(-0.6%) | -$20.56 M(+5.5%) |
| Sept 2017 | - | -$5.34 M(+62.2%) | -$19.48 M(+3.6%) |
| June 2017 | - | -$3.29 M(-50.3%) | -$18.81 M(+2.6%) |
| Mar 2017 | - | -$6.63 M(+56.9%) | -$18.33 M(+24.5%) |
| Dec 2016 | -$14.72 M(-62.9%) | -$4.22 M(-9.5%) | -$14.72 M(-5.2%) |
| Sept 2016 | - | -$4.67 M(+65.8%) | -$15.53 M(-14.2%) |
| June 2016 | - | -$2.81 M(-6.8%) | -$18.11 M(-49.3%) |
| Mar 2016 | - | -$3.02 M(-40.1%) | -$35.70 M(-10.0%) |
| Dec 2015 | -$39.65 M(-5.7%) | -$5.04 M(-30.5%) | -$39.65 M(-11.3%) |
| Sept 2015 | - | -$7.24 M(-64.5%) | -$44.72 M(-2.5%) |
| June 2015 | - | -$20.40 M(+192.4%) | -$45.89 M(+19.0%) |
| Mar 2015 | - | -$6.98 M(-31.0%) | -$38.57 M(-8.3%) |
| Dec 2014 | -$42.07 M(-2.6%) | -$10.11 M(+20.2%) | -$42.07 M(-2.9%) |
| Sept 2014 | - | -$8.41 M(-35.7%) | -$43.34 M(-5.3%) |
| June 2014 | - | -$13.08 M(+24.8%) | -$45.76 M(+3.7%) |
| Mar 2014 | - | -$10.47 M(-7.9%) | -$44.11 M(+2.1%) |
| Dec 2013 | -$43.20 M(+27.0%) | -$11.38 M(+5.1%) | -$43.20 M(+5.2%) |
| Sept 2013 | - | -$10.83 M(-5.2%) | -$41.08 M(+2.1%) |
| June 2013 | - | -$11.43 M(+19.4%) | -$40.24 M(+13.1%) |
| Mar 2013 | - | -$9.57 M(+3.3%) | -$35.58 M(+4.6%) |
| Dec 2012 | -$34.00 M(-34.6%) | -$9.26 M(-7.3%) | -$34.00 M(-8.8%) |
| Sept 2012 | - | -$9.99 M(+47.6%) | -$37.29 M(-31.5%) |
| June 2012 | - | -$6.77 M(-15.3%) | -$54.47 M(-1.6%) |
| Mar 2012 | - | -$7.99 M(-36.3%) | -$55.38 M(+6.5%) |
| Dec 2011 | -$52.02 M(+34.3%) | -$12.54 M(-53.8%) | -$52.02 M(+7.4%) |
| Sept 2011 | - | -$27.17 M(+253.8%) | -$48.42 M(+70.4%) |
| June 2011 | - | -$7.68 M(+66.1%) | -$28.41 M(+2.4%) |
| Mar 2011 | - | -$4.62 M(-48.3%) | -$27.75 M(-28.4%) |
| Dec 2010 | -$38.74 M | -$8.95 M(+25.0%) | -$38.74 M(+3.3%) |
| Sept 2010 | - | -$7.16 M(+2.0%) | -$37.49 M(+6.1%) |
| June 2010 | - | -$7.02 M(-55.0%) | -$35.32 M(+14.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2010 | - | -$15.61 M(+102.9%) | -$30.91 M(+66.7%) |
| Dec 2009 | -$18.54 M(-54.9%) | -$7.69 M(+54.2%) | -$18.54 M(-12.0%) |
| Sept 2009 | - | -$4.99 M(+91.3%) | -$21.07 M(-8.0%) |
| June 2009 | - | -$2.61 M(-19.6%) | -$22.91 M(-43.7%) |
| Mar 2009 | - | -$3.25 M(-68.2%) | -$40.69 M(-1.0%) |
| Dec 2008 | -$41.11 M(+105.8%) | -$10.22 M(+49.6%) | -$41.11 M(-4.6%) |
| Sept 2008 | - | -$6.83 M(-66.5%) | -$43.08 M(+23.9%) |
| June 2008 | - | -$20.39 M(+455.9%) | -$34.77 M(+78.5%) |
| Mar 2008 | - | -$3.67 M(-69.9%) | -$19.48 M(-2.5%) |
| Dec 2007 | -$19.98 M(-15.3%) | -$12.19 M(-928.7%) | -$19.98 M(+21.8%) |
| Sept 2007 | - | $1.47 M(-128.9%) | -$16.40 M(-33.1%) |
| June 2007 | - | -$5.10 M(+22.5%) | -$24.50 M(-2.3%) |
| Mar 2007 | - | -$4.16 M(-51.7%) | -$25.07 M(+6.3%) |
| Dec 2006 | -$23.59 M(+44.2%) | -$8.61 M(+29.9%) | -$23.59 M(+7.7%) |
| Sept 2006 | - | -$6.63 M(+17.0%) | -$21.90 M(+22.4%) |
| June 2006 | - | -$5.67 M(+111.1%) | -$17.89 M(+13.7%) |
| Mar 2006 | - | -$2.68 M(-61.2%) | -$15.73 M(-3.8%) |
| Dec 2005 | -$16.36 M(-375.7%) | -$6.92 M(+163.6%) | -$16.36 M(+5.6%) |
| Sept 2005 | - | -$2.62 M(-25.2%) | -$15.50 M(-5.5%) |
| June 2005 | - | -$3.51 M(+5.9%) | -$16.41 M(-369.5%) |
| Mar 2005 | - | -$3.31 M(-45.3%) | $6.09 M(+2.6%) |
| Dec 2004 | $5.94 M(-116.4%) | -$6.06 M(+71.4%) | $5.94 M(-0.0%) |
| Sept 2004 | - | -$3.53 M(-118.6%) | $5.94 M(+112.9%) |
| June 2004 | - | $18.99 M(-647.8%) | $2.79 M(-108.0%) |
| Mar 2004 | - | -$3.47 M(-42.7%) | -$34.87 M(-3.5%) |
| Dec 2003 | -$36.13 M(+34.2%) | -$6.05 M(-9.4%) | -$36.13 M(+2.3%) |
| Sept 2003 | - | -$6.68 M(-64.2%) | -$35.32 M(-10.0%) |
| June 2003 | - | -$18.66 M(+294.8%) | -$39.26 M(+43.0%) |
| Mar 2003 | - | -$4.73 M(-9.9%) | -$27.46 M(+2.0%) |
| Dec 2002 | -$26.92 M(-34.1%) | -$5.25 M(-50.6%) | -$26.92 M(-7.4%) |
| Sept 2002 | - | -$10.62 M(+54.7%) | -$29.07 M(-23.9%) |
| June 2002 | - | -$6.87 M(+64.2%) | -$38.20 M(-4.3%) |
| Mar 2002 | - | -$4.18 M(-43.5%) | -$39.90 M(-2.3%) |
| Dec 2001 | -$40.84 M(+41.2%) | -$7.40 M(-62.5%) | -$40.84 M(+2.8%) |
| Sept 2001 | - | -$19.75 M(+130.6%) | -$39.72 M(+54.2%) |
| June 2001 | - | -$8.56 M(+67.2%) | -$25.76 M(-5.3%) |
| Mar 2001 | - | -$5.12 M(-18.4%) | -$27.20 M(-6.0%) |
| Dec 2000 | -$28.92 M(-424.1%) | -$6.28 M(+8.2%) | -$28.92 M(+1488.9%) |
| Sept 2000 | - | -$5.80 M(-42.0%) | -$1.82 M(-230.6%) |
| June 2000 | - | -$10.00 M(+46.1%) | $1.39 M(-76.7%) |
| Mar 2000 | - | -$6.84 M(-132.9%) | $5.98 M(-32.9%) |
| Dec 1999 | $8.92 M(-139.2%) | $20.82 M(-905.2%) | $8.92 M(-135.6%) |
| Sept 1999 | - | -$2.59 M(-52.2%) | -$25.06 M(-13.5%) |
| June 1999 | - | -$5.41 M(+38.5%) | -$28.98 M(+24.5%) |
| Mar 1999 | - | -$3.91 M(-70.3%) | -$23.27 M(+2.2%) |
| Dec 1998 | -$22.76 M(-75.6%) | -$13.16 M(+102.5%) | -$22.76 M(+54.9%) |
| Sept 1998 | - | -$6.50 M(-2266.7%) | -$14.70 M(+17.6%) |
| June 1998 | - | $300.00 K(-108.8%) | -$12.50 M(-84.2%) |
| Mar 1998 | - | -$3.40 M(-33.3%) | -$79.10 M(-15.2%) |
| Dec 1997 | -$93.30 M(+725.7%) | -$5.10 M(+18.6%) | -$93.30 M(+2.8%) |
| Sept 1997 | - | -$4.30 M(-93.5%) | -$90.80 M(+2.1%) |
| June 1997 | - | -$66.30 M(+276.7%) | -$88.90 M(+273.5%) |
| Mar 1997 | - | -$17.60 M(+576.9%) | -$23.80 M(+110.6%) |
| Dec 1996 | -$11.30 M(+9.7%) | -$2.60 M(+8.3%) | -$11.30 M(+29.9%) |
| Sept 1996 | - | -$2.40 M(+100.0%) | -$8.70 M(+38.1%) |
| June 1996 | - | -$1.20 M(-76.5%) | -$6.30 M(+23.5%) |
| Mar 1996 | - | -$5.10 M | -$5.10 M |
| Dec 1995 | -$10.30 M | - | - |
FAQ
- What is Core Laboratories NV annual cash flow from investing activities?
- What is the all time high annual CFI for Core Laboratories NV?
- What is Core Laboratories NV annual CFI year-on-year change?
- What is Core Laboratories NV quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Core Laboratories NV?
- What is Core Laboratories NV quarterly CFI year-on-year change?
- What is Core Laboratories NV TTM cash flow from investing activities?
- What is the all time high TTM CFI for Core Laboratories NV?
- What is Core Laboratories NV TTM CFI year-on-year change?
What is Core Laboratories NV annual cash flow from investing activities?
The current annual CFI of CLB is -$6.65 M
What is the all time high annual CFI for Core Laboratories NV?
Core Laboratories NV all-time high annual cash flow from investing activities is $8.92 M
What is Core Laboratories NV annual CFI year-on-year change?
Over the past year, CLB annual cash flow from investing activities has changed by -$2.80 M (-72.51%)
What is Core Laboratories NV quarterly cash flow from investing activities?
The current quarterly CFI of CLB is -$491.00 K
What is the all time high quarterly CFI for Core Laboratories NV?
Core Laboratories NV all-time high quarterly cash flow from investing activities is $20.82 M
What is Core Laboratories NV quarterly CFI year-on-year change?
Over the past year, CLB quarterly cash flow from investing activities has changed by +$2.90 M (+85.51%)
What is Core Laboratories NV TTM cash flow from investing activities?
The current TTM CFI of CLB is -$5.28 M
What is the all time high TTM CFI for Core Laboratories NV?
Core Laboratories NV all-time high TTM cash flow from investing activities is $11.63 M
What is Core Laboratories NV TTM CFI year-on-year change?
Over the past year, CLB TTM cash flow from investing activities has changed by -$2.13 M (-67.76%)